Bulletin
Investor Alert

New York Markets Open in:

Marinus Pharmaceuticals Inc.

NAS: MRNS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/208112000/composite

$

3.14

Change

0.00 -75.00%

Volume

Volume 24,056

Sep 22, 2020, 7:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208112000/composite

Previous close

$ 12.63

$ 12.56

Change

-0.07 -0.55%

Day low

Day high

$2.96

$3.22

Open
Open: 3.14

52 week low

52 week high

$2.96

$16.28

Open

Market cap

$392.24M

Average volume

1.44M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.99

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrns

MarketWatch News on MRNS

  1. Marinus Pharmaceuticals started at outperform with $6 stock price target at Oppenheimer

    8:31 a.m. Dec. 20, 2019

    - Tomi Kilgore

  2. Marinus Pharma stock price target cut to $6 from $7 at Leerink

    8:59 a.m. Dec. 12, 2019

    - Ciara Linnane

  3. Marinus Pharma reiterated as outperform at Leerink

    2:22 p.m. Dec. 9, 2019

    - Ciara Linnane

  4. 5 stocks trading at under $10 worth discovering

    12:46 p.m. June 27, 2019

    - Michael Brush

  5. Harry Boxer’s four health-care stocks to watch

    12:54 p.m. July 12, 2018

    - Harry Boxer

  6. Bain Makes Bank in Two Rebounding Biotechs

    8:58 a.m. Dec. 21, 2017

    - Barron's Online

  7. Marinus Pharma stock surges on positive mid-stage data for rare genetic disorder drug

    11:41 a.m. Jan. 23, 2017

    - Emma Court

  8. Marinus Pharma stock surges 45% to $1.69 per share

    11:39 a.m. Jan. 23, 2017

    - Emma Court

  9. Marinus Pharmaceuticals stock price target cut to $2 from $14 at RBC Capital

    7:42 a.m. June 14, 2016

    - Tomi Kilgore

  10. Marinus Pharmaceuticals downgraded to sector perform from market perform at RBC Capital

    7:42 a.m. June 14, 2016

    - Tomi Kilgore

  11. Marinus Pharmaceuticals shares down 58% in premarket trade

    8:03 a.m. June 13, 2016

    - Ciara Linnane

  12. Marinus Pharma says late-stage trial of treatment for adjust focal onset seizures failed to meet goals

    7:36 a.m. June 13, 2016

    - Ciara Linnane

  13. Marinus Pharma says to discontinue program

    7:37 a.m. June 13, 2016

    - Ciara Linnane

  14. Marinus Pharma shares halted in premarket trade

    7:37 a.m. June 13, 2016

    - Ciara Linnane

  15. Almost half of venture-backed IPOs this year are losers

    6:00 a.m. Oct. 3, 2014

    - Philip van Doorn

Analyst Ratings

/news/nonmarketwatch/company/us/mrns

Other News on MRNS

  1. Marinus reverse split shares 1:4

    9:28 a.m. Sept. 22, 2020

    - Seeking Alpha

  2. Healthcare ETFs, Stocks That Gained Double Digits Last Week

    10:05 a.m. Sept. 21, 2020

    - Zacks.com

  3. ADT, NKLA among premarket losers

    8:20 a.m. Sept. 16, 2020

    - Seeking Alpha

  4. Marinus (MRNS) Received its Third Buy in a Row

    7:30 a.m. Sept. 16, 2020

    - SmarterAnalyst

  5. OCN, PSTV, VXRT and SAVA among midday movers

    12:40 p.m. Sept. 15, 2020

    - Seeking Alpha

  6. NEE, NVAX among premarket gainers

    8:36 a.m. Sept. 15, 2020

    - Seeking Alpha

  7. Marinus (MRNS) Receives a Buy from Ladenburg Thalmann & Co.

    7:55 a.m. Sept. 15, 2020

    - SmarterAnalyst

  8. Marinus (MRNS) Gets a Buy Rating from H.C. Wainwright

    6:25 a.m. Sept. 15, 2020

    - SmarterAnalyst

  9. Oppenheimer Sticks to Their Buy Rating for Marinus (MRNS)

    6:06 a.m. Sept. 15, 2020

    - SmarterAnalyst

  10. Marinus trades high on development contract with BARDA

    8:52 a.m. Sept. 14, 2020

    - Seeking Alpha

  11. NVDA, ORCL among premarket gainers

    8:39 a.m. Sept. 14, 2020

    - Seeking Alpha

  12. Marinus (MRNS) Receives a Buy from Oppenheimer

    9:35 p.m. Sept. 7, 2020

    - SmarterAnalyst

  13. Oppenheimer Assigns a Buy Rating on Marinus (MRNS)

    3:10 p.m. Aug. 7, 2020

    - SmarterAnalyst

  14. 10-Q: MARINUS PHARMACEUTICALS INC

    5:18 p.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  15. Loading more headlines...
/news/pressrelease/company/us/mrns

Press Releases on MRNS

  1. Marinus Announces One-for-Four Reverse Stock Split

    9:14 a.m. Sept. 22, 2020

    - BusinessWire - BZX

  2. Marinus Climbs on Trial Results

    10:30 a.m. Sept. 15, 2020

    - Baystreet.ca

  3. Ganaxolone - Emerging Insight and Market Forecast - 2030

    7:16 a.m. Aug. 26, 2020

    - GlobeNewswire

  4. Marinus Pharmaceuticals Appoints Charles Austin to Board of Directors

    4:00 p.m. July 29, 2020

    - BusinessWire - BZX

  5. Marinus Pharmaceuticals Provides Pipeline Update

    7:00 a.m. June 30, 2020

    - GlobeNewswire

  6. Marinus Pharmaceuticals Provides Pipeline Update

    7:00 a.m. June 30, 2020

    - GlobeNewswire

  7. Research Uncovers New Role Psychedelics Could Play in Therapy

    9:00 a.m. June 25, 2020

    - PR Newswire - PRF

  8. Marinus Pharmaceuticals to Host Pipeline Update Webinar

    8:00 a.m. June 24, 2020

    - GlobeNewswire

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.